A recent study conducted suggests that the outcomes of a first Prostate Specific Antigen or PSA test for men from 44 to 50 years old can actually estimate and predict the risk of dying from prostate cancer within the succeeding 25-30 years.
In the said research, the proponents of the study analyzed and evaluated collected blood samples from 12,090 Swedish men from 197 to 1986 when they were still relatively younger between aged 44 and 50. Some 5,000 men after six years had samples collected for the same purpose; samples were also collected from 1,167 males who were 60 years old.
Taken into consideration the results of the study, lead author, Dr. Hans Lilja remarked in a news release, “This research helps us distinguish between those men who may benefit from regular PSA screening for prostate cancer and those men who may not need to be screened so frequently.”
He further added, “Instead of testing all men each year or every two years, screening and surveillance efforts can be focused on early detection of prostate cancer in those men who are found to be at high risk of death from the disease.”